These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2058629)
21. [HBeAg and anti-HBe levels in HBsAg positive blood donors]. Hasçelik G; Günalp A Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096 [TBL] [Abstract][Full Text] [Related]
22. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece. Gigi E; Lalla T; Orphanou E; Sinakos E; Vrettou E; Raptopoulou-Gigi M J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284 [TBL] [Abstract][Full Text] [Related]
23. [Anti-HBs-F(ab)'2 to the seroconversion of HBsAg carriers]. An P Zhonghua Yi Xue Za Zhi; 1992 Nov; 72(11):647-50, 701. PubMed ID: 1338699 [TBL] [Abstract][Full Text] [Related]
24. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers. Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter? Thakur V; Guptan RC; Malhotra V; Basir SF; Sarin SK J Assoc Physicians India; 2002 Nov; 50():1386-94. PubMed ID: 12583467 [TBL] [Abstract][Full Text] [Related]
26. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand. Hopkirk N; Moyes CD; Lucas CR N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277 [TBL] [Abstract][Full Text] [Related]
27. HBeAg/anti-HBe antigenic system in liver diseases in Greece. Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477 [TBL] [Abstract][Full Text] [Related]
28. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis]. Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039 [No Abstract] [Full Text] [Related]
29. Vertical transmission of HBV from mothers HBsAg positive, anti-HBe positive. Gussetti N; Pornaro E; Largajolli G; D'Elia R Dev Biol Stand; 1983; 54():405-8. PubMed ID: 6653895 [TBL] [Abstract][Full Text] [Related]
30. Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection. Pastore G; Dentico P; Angarano G; Lapedota E; Schiraldi O Hepatogastroenterology; 1981 Feb; 28(1):20-2. PubMed ID: 7216135 [TBL] [Abstract][Full Text] [Related]
31. The prevalence of hepatitis B surface antigen (HBsAg) among drug-dependent patients in Jeddah, Saudi Arabia. Njoh J East Afr Med J; 1995 Mar; 72(3):198-9. PubMed ID: 7796776 [TBL] [Abstract][Full Text] [Related]
32. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe. Zhang K; Imazeki F; Fukai K; Arai M; Kanda T; Mikata R; Yokosuka O J Med Virol; 2007 Jun; 79(6):683-93. PubMed ID: 17457922 [TBL] [Abstract][Full Text] [Related]
33. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection. Perrillo R; Campbell C; Wellinghoff W; Gelb L Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131 [TBL] [Abstract][Full Text] [Related]
35. [ Subtypes of HBsAG in Morocco: general distribution in HBsAG carriers in Casablanca in terms of their clinical state. Relations with the markers of the HBe system]. Rioche M Bull Soc Pathol Exot Filiales; 1986; 79(2):191-8. PubMed ID: 3089637 [TBL] [Abstract][Full Text] [Related]
36. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers. Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057 [TBL] [Abstract][Full Text] [Related]
37. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey. Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248 [TBL] [Abstract][Full Text] [Related]
38. Serum hepatitis B virus DNA: relationship with the e-antigen and anti-e status in chronic carriers. Yap SF; Wong NW; Goh KL Malays J Pathol; 1994 Jun; 16(1):57-62. PubMed ID: 16329577 [TBL] [Abstract][Full Text] [Related]
39. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil]. Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. Kao JH; Chen PJ; Lai MY; Chen DS J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]